Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)

109 filings reported holding STOK - Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2021.
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 35,383,061 shares of 54,711,345 outstanding shares and own 64.67% of the company stock.
Largest 10 shareholders include Skorpios Trust (14,443,681 shares), RTW INVESTMENTS, LP (3,644,248 shares), FMR LLC (2,554,797 shares), Redmile Group, LLC (2,246,668 shares), VANGUARD GROUP INC (1,912,182 shares), BlackRock Inc. (1,482,265 shares), Cormorant Asset Management, LP (1,182,362 shares), GILDER GAGNON HOWE & CO LLC (1,072,440 shares), STATE STREET CORP (796,852 shares), and Octagon Capital Advisors LP (783,769 shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.